Chromatin immunoprecipitation followed by massively parallel sequencing (ChIP-Seq) is a powerful technique to map the genomic location of a given chromatin bound factor (i.e., transcription factors, co-factors) or epigenetic marks, such as histone modification. The procedure is based on, crosslinking of proteins to DNA followed by the capture of the protein-DNA complexes by "ChIP-grade" antibodies. In this chapter we describe in detail the experimental method developed in our laboratory to investigate in vivo the DNA binding characteristics of a key heterodimeric nuclear receptor, the Retinoid X Receptor (RXR) in murine bone marrow derived macrophages.
Introduction
Nuclear hormone receptors are lipid activated transcription factors that regulate gene expression in a ligand dependent manner. They possess an evolutionarily conserved domain structure, which consists of a DNA binding domain responsible for the recognition of a specific motif encoded in the genome, a ligand binding domain for binding the activator ligand and the transactivation domain for transcription initiation. Ligand binding leads to conformation changes on the surface of the receptor, followed by a co-repressor -co-activator switch/exchange, which then results in a distinct change in gene transcription (reviewed in 1).
RXR is an essential member of the nuclear receptor family, because it forms heterodimers with other nuclear hormone receptors (Liver X Receptor, LXR; Peroxisome Proliferator Activated Receptor, PPAR; Retinoic Acid Receptor, RAR etc.) that regulate indispensable biological processes such as inflammation, lipid and glucose metabolism (2, 3) . RXR was discovered as a novel retinoid responsive transcription factor (4) . Several ligands, such as 9-cis retinoic acid, docosahexanoic acid and phytanic acid have been shown to activate the receptor, although their action as endogenous ligands under physiological conditions have not been proven yet (5) . There are also specific and selective synthetic agonists of RXR, such as
LG100268 or LG10069 (Bexarotene) (6, 7) .
RXR has three different isotypes in metazoans (RXR, RXR, RXR), which display differential expression patterns in different tissues. For example, RXR is expressed in heart, liver, kidney, spleen and placenta epidermis, RXR is specific to brain and muscle, while RXR is ubiquitous (5) . The phenotypes attributable to these isoforms have been well characterized. For instance, abolished expression of RXR was shown to be lethal at embryonic stage E13.5-16.5 mostly due to cardiac abnormalities, while the lack of RXR or RXR was not fatal, but resulted in male infertility and increased metabolic rate. These 4 studies also revealed a locomotor deficiency in RXR/ double knock out mice (8, 9) . In cells of myeloid origin RXR appears to be the dominant isoform (10, 11) .
On the other hand, activation of RXR and the molecular details of RXR mediated gene expression remains enigmatic, because: 1. Definitve proof for a biological role for an endogenous ligand is still lacking. 2. It is not clear if it also has heterodimer independent activities.
ChIP-Seq has become the most widely used and effective method to study chromatin state and transcription factor distribution at the genomic level. ChIP was almost the first application linked to next generation sequencing and the one leading to the determination of the typical histone acetylation and methylation patterns of gene promoters, enhancers, insulators and repressed chromatin territories (12) . ChIP-Seq also allows the determination of the "cistrome" of any transcription factor meaning -all the binding sites in a given cell type under given circumstances, which was first carried out for Signal Transducer and Activator of Transcription (STAT) 1 (13) . Macrophages are a major target of research including studies on immune function, but also in metabolism and transcriptional regulation as well (14, 15) . This is not only because their relatively easy accessibility, but also due to their importance in physiological as well as pathological processes.
In order to better understand the molecular mechanisms by which RXR regulates gene expression in a genome-wide manner in murine bone marrow derived macrophages, a protocol was developed in our laboratory to accurately map the receptor binding sites using ChIP-Seq. This protocol is described in this chapter (Figure 1 ).
The protocol here described is optimized to murine bone marrow derived macrophages. A similar approach was used by us to determine the RXR cistrome in HeLa cells (16) .
Optimization to other cell types would be required especially regarding cross-linking and sonication.
Materials
1. Bone marrow derived macrophages obtained from the femur of C57Bl6/J male animals as described (17) . Briefly, bone-marrow was flushed, cells were purified through a Ficoll-Paque gradient and cultured in DMEM containing 20% endotoxinreduced fetal bovine serum and 30% L929 conditioned medium for 5 days. On the sixth day DMEM is replaced to Macrophage serum free media for 24 hours, then treatments are performed.
DSG Di (N-succinimidyl) glutarate (see Note 1).

DMSO (dimethyl-sulfoxide).
4. DMSO/EtOH (1:1) as vehicle treatment. 
LG268 (Ligand Pharmaceuticals
)
100% Ethanol (ETOH).
19. Agilent 2100 Bioanalyzer with 7500 chips for inputs, 1000 chips for DNA libraries. 
Methods
Prepare the lysis, dilution and shearing buffers by dissolving the protease inhibitor tablets according to the manufacturer's instructions. Make sure that you have sufficient amount of PBS at room temperature and at 4°C (20 ml ice-cold PBS for washing/ plate, 20 ml PBS at room temperature for cross-linking/ plate). 10. Place the samples on ice.
11. Aspirate the liquid from the plates and wash the cells twice with ice-cold PBS. Make sure that after the second wash all the supernatant is discarded, then immediately proceed to lysis.
Cell lysis and chromatin shearing
1. Scrape up the cells from each plate in 1 ml Cell Lysis/Wash Buffer containing appropriate amount of protease inhibitors (see Note 3).
2. Transfer the lysates to 1.5 ml centrifuge tubes.
3. Centrifuge with 12.000 x g for one minute at 4°C.
4.
Remove the supernatant and add 1 ml of Cell Lysis/ Wash Buffer.
5. Pipette up and down the cells at least 20 times to get homogenous cell suspension, and then push through the whole volume in a 1 ml insulin syringe.
6. Repeat the step 3.
7. Remove the supernatants and combine the pellets into one centrifuge tube, using the same 1 ml Lysis Buffer. Push the whole volume again through a 1 ml insulin syringe.
8. Repeat the step 3.
9. Remove the supernatant and resuspend the nuclear pellet in 1 ml of room temperature Shearing Buffer (see Note 4).
Gently pipette up and down at least 30 times to generate a homogenous suspension
and take care not to generate bubbles (see Note 5). 14. Transfer 900 μl supernatant to a new 15 ml conical tube and dilute 10 fold by adding 8.1 ml Dilution Buffer containing protease inhibitors. The diluted chromatin can be stored for 24 hours at 4°C.
Transfer the solutions into 15 ml conical tubes (polystyrene) (see
Immunoprecipitation
1. Add 5 μg of anti-RXR antibody to each diluted chromatin.
2. Set aside at least 1 ml of diluted chromatin and add 5 μg of pre-immune rabbit IgG, as a control of nonspecific binding.
3. Incubate the samples overnight at 4°C, using an 'end-over-end' rotator.
4. On the day of immunoprecipitation, pre-block the paramagnetic beads. For each immunoprecipitation, prepare 190 μl of beads. Wash the beads three times with 1 ml of PBS containing 0.5% BSA, using the magnetic rack appropriate for 1.5 ml centrifuge tubes. Incubate the beads overnight at 4°C using rotator (see Note 11). 14. Add 1 ml ice-cold TE Buffer. Gently pipette up and down to generate homogenous bead slurry then transfer the whole volume to a 1.5 ml LoBind tube.
After overnight incubation
15. Place the LoBind tubes on a magnetic rack, which stands on ice. Wait until the liquid appears clear then remove the supernatant (see Note 14).
Bead elution, de-crosslinking and DNA purification
The remaining part of the protocol should be carried out at room temperature.
1. Add 100 μl Bead elution buffer to each tube and vortex at moderate speed for a few seconds. Place the samples on a thermomixer for 15 minutes and shake at 1000 rpm.
2. Place the tubes back on the magnetic rack and collect the supernatant into clean LoBind tubes.
3. Repeat the step 1.
4. Store and use Shearing Buffer at room temperature, because SDS precipitation occurs at 4°C. This negatively affects sonication efficiency. If SDS precipitation occurs in the nuclear lysate, allow the solution to come to room temperature before sonication.
5. Be careful not to generate bubbles during lysis, which can negatively affect sonication efficiency.
6. It is highly recommended to use polystyrene tubes, instead of polypropylene, since polystyrene transfers sonic waves more efficiently.
7. The probes should be set exactly in the middle of the tube submerged in the solution.
If the probes come in contact with the inner surface of the tubes it might negatively affect sonication efficiency.
8. Check the position of the probes after each sonication cycle to make sure they not to touch the tube. 12. Be careful not to disturb the chromatin-antibody complexes after centrifugation. Use only the top 90% of the sample to avoid high background signal.
13. To avoid incomplete mixing of the magnetic beads and the antibody-chromatin complexes see Note 11 for instructions.
14. Use 1 ml pipette tips to remove all the supernatants at this step, because the beads are loosely attached to the tube surface.
15. Adsorption of DNA to the silica during column purification is drastically reduced at higher pH. It is important to follow the manufacturer's instructions to acidify the DNA solution prior to binding to the column.
16. To determine the background of the experiment prepare control libraries with the input DNA and DNA obtained from samples immunoprecipitated with control IgG.
